RESULTS OF SCIENTIFIC ACTIVITIES OF THE NATIONAL INSTITUTE OF MEDICINAL MATERIALS (2016–2025) AND DEVELOPMENT ORIENTATION TOWARD 2030

Tóm tắt

 This article provides a comprehensive review of the scientific and technological (S&T) activities of the National Institute of Medicinal Materials (NIMM), Ministry of Health of Vietnam, during the 2021–2025 period, and outlines strategic development orientations toward 2030 to mark the Institute's 65th anniversary (1961–2026). During 2021–2025, NIMM conducted 443 S&T research projects across national, ministerial, local, and grassroots levels; published 563 scientific papers (representing a 48.2% increase over the preceding period, including 135 international publications which alone saw an 82.4% increase); conferred 25 doctoral degrees; officially registered 10 medicinal plant varieties for commercial circulation; issued 97 technical procedures for medicinal plant breeding and production; isolated more than 250 pure compounds; established 27 reference compouds; and research & developed of 7 herbal pharmaceutical formulations. Research activities were systematically organised along a value chain spanning genetic resources, variety selection, chemical analysis and standardization, herbal drug formulation, and modernization of traditional medicines. In addition to these achievements, the article acknowledges persistent limitations regarding equipment and facilities, especially in the context of deep international integration in science and technology, as well as the adaptability of scientists to the new situation when implementing the Politburo Resolution No. 57-NQ/TW dated December 22, 2024 on breakthroughs in the development of science, technology, innovation, and national digital transformation, and the Law on Science, Technology and Innovation No. 93/2025/QH15. To leverage its strategic advantages and adapt to the evolving landscape, the Institute prioritizes research across the entire value chain, developing a diverse portfolio of medicinal products to enhance primary healthcare. Our mission remains steadfast in fostering in-depth and applied research driven by advanced science and technology, while elevating the collective research capacity to meet international standards. Moving forward, NIMM will focus on institutional and governance reforms, accelerating digital transformation, and establishing a comprehensive medicinal resource database. Furthermore, by implementing robust intellectual property protections and fostering public-private partnerships, we aim to drive revenue growth, strengthen institutional self-reliance, and improve the welfare and living standards of our staff